Shilpa Medicare Ltd Quarterly Result

Shilpa Medicare Ltd Quarterly Result

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

Net Profit - Last Quarter

₹ 107.79 Cr.

Last updated on: Jul 31, 2026

Shilpa Medicare Ltd Quarterly Results Key Highlights

  • The revenue of Shilpa Medicare Ltd for the Mar '26 is ₹ 482 crore as compare to the Dec '25 revenue of ₹ 410.54 crore.
  • This represent the growth of 17.41% The ebitda of Shilpa Medicare Ltd for the Mar '26 is ₹ 164.72 crore as compare to the Dec '25 ebitda of ₹ 101.89 crore.
  • This represent the growth of 61.66% The net profit of Shilpa Medicare Ltd for the Mar '26 is ₹ 107.79 crore as compare to the Dec '25 net profit of ₹ 44.58 crore.
  • This represent the growth of 141.79%.

Shilpa Medicare Ltd Quarterly Results Analysis

Market Price of Shilpa Medicare Ltd

1M

1Y

3Y

5Y

Monitoring Shilpa Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
31 Jul 2026611.55
30 Jul 2026603.6
29 Jul 2026604.65
28 Jul 2026605.3
27 Jul 2026620.9
24 Jul 2026607
23 Jul 2026603.15
22 Jul 2026613.45
21 Jul 2026639.35
20 Jul 2026625.6

Historical Revenue of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical EBITDA of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Shilpa Medicare Ltd

No data available

* All values are in crore

Shilpa Medicare Ltd News Hub

Shilpa Medicare to conduct AGM

Shilpa Medicare announced that the 37th Annual General Meeting (AGM) of the company will be held on

Read more

16 Aug 24

Shilpa Medicare consolidated net profit rises 1091.53% in the June 2024 quarter

Net profit of Shilpa Medicare rose 1091.53% to Rs 14.06 crore in the quarter ended June 2024 as agai

Read more

08 Aug 24

Shilpa Medicare to announce Quarterly Result

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 8 August 2024. Power

Read more

02 Aug 24

Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) announced the submission of NDA to U.S. FDA for Oxylanth

Read more

04 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Shilpa Medicare Ltd

  • Shilpa Medicare Limited, formerly known as Shilpa Antibiotics Private Limited was incorporated as a Private Company on November 20, 1987.
  • The Company changed the status to Public and the name of the Company changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003. The Company has been promoted by Vishnukant C. Bhutada and his Associates and is engaged in manufacturing of API, Formulation and Development service.
  • The Company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka.
  • It then started commercial production in November, 1989. The Company is one of the leading API and formulations manufacturers with strong capabilities in the therapeutic area of oncology.
  • It supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various regulated markets including USA, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets.

FAQs for Quarterly Results of Shilpa Medicare Ltd

What key financial metrics are included in Shilpa Medicare Ltd's quarterly results?

Key financial metrics in Shilpa Medicare Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Shilpa Medicare Ltd announce its quarterly results?

Shilpa Medicare Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Shilpa Medicare Ltd's quarterly performance impact its stock price?

Shilpa Medicare Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Shilpa Medicare Ltd's quarterly results on dividends?

The impact of Shilpa Medicare Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Shilpa Medicare Ltd's quarterly results?

Yes, Shilpa Medicare Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions